Ovine fetal cerebral artcries exhibit an enhanced contractile response to norepinephrine (NH) compared with newborns and adults. It is possible that P-adrenergic receptors and/or nitric oxide (NO), a putative endothelium-dependent relaxing factor, differentially modulate cerebrovascular responsiveness to NE as a function of developmcnt. 'l'he present study evaluated the effect of thc P-adrenoceptor antagonist, propranolol, and the NO synthasc inhibitor, N~-nitro-I.-arginine methyl estcr (I,NAME), on the contractile response of isolated middle cerebral artery (MCA) and basilar artery (BA) to NIi during fetal development. MCAs isolated from four preterm fetal lambs (105 d of gestation), seven near-term fetal lambs (125-130 d of gestation), and eight newborn lambs (2-7 d of age) were evaluated using organ baths. BAS isolated from the near-term fetal and newborn lambs were also evaluated. Contractile reactivity of MCAs to NB dccreased significantly during fetal maturation as manifested by a marked decrease in F,,,,, (maximal relative contractile force generated) and an increase in EC,,, (F,,, -100 -+ 7,41 -+ 7, and 28 r 8% of KC1 contraction; HC,,,-0.14 + 0.03, 1.09 :+-0.36, and 1.07 + 0.22 pM for preterm fetus, near-term fetus, and newborn lamb MCAs, respectively, p 5 0.05). Propranolol treatment M) increased F,,,, (2-fold) only for newborn lamb MCAs. Pretreatnlent with LNAME (10 '' M) markedly enhanced rhc contractile T h e activation of the sympatho-adrenal axis is considered to be unimportant to the regulation of cerebral blood flow in adults (1, 2); however, such is not necessarily the case for the fetus and neonate. Activation of sympathetic nerves constricted cerebral arterioles and decreased cerebral blood flow in newborn and Letal animal models (3-6). In addition, fetal cerebral arteries, both in vivo and in vitro, exhibited cnhanced reactivity to the sympathetic neurotransmitter, norepinephrine (NE) (7-9). 'l'hese reports suggest that the neuroeffector system may be an important factor with respect to the developing cerebral response to NE (7-fold decrease in EC,, and 2-fold increase in F',,,,, p < 0.05) for near-term fetus MCAs, whereas preterm fetus and newborn lamb MCAs were unaffected by the inhibitor. 13.4s were unresponsive to NE except for near-term fetus BAS in the presence of LNAMIX. 'l'he eEcct of NO-synthase inhibition on NE contractility was dependent on developmental age, being prominent near term. The data suggest that, in the more mature fetus, NO, presumably derived from endothelium, bchaves as a functional antagonist to sympathetic vasoconstriction of the cerebrovasculature, and its apparent absence permits unrepressed sympathetic vasoconstriction in the premature brain. (Pediatr Hes 38: 237-242, 1995) Abbreviations NE:, norepinephrine NO, nitric oxide MCA, middle cerebral artery BA, basilar artery LNAME, N~-nitro-L-arginine methyl ester EC,,, effective drug concentration inducing 50% of maximal response F,,,, maximal force generated in response to drug circulation and indicate that the maturation process is associated with a progressive loss of sympathetic reactivity.
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A s yet, the underlying mechanism(s) by which a-adrenergic contraction is modulated during fetal and postnatal life is not known. Endothelium-dependent relaxing factor(s) are reported to interfere with NE-induced contractions (10) (11) (12) (13) (14) , and ontogenic changes in endothelial nitric oxide (NO) production have been demonstrated in the pulmonary circulation of fetal sheep (15) . 'l'he absence of endothelium-dependent relaxation in the immature cerebral circulation might effect an enhanced response to contractile stimuli. However, the fact that a functional cholinergic vasodilator capability was expressed in fetal early in fetal life (16) . In addition to NO, alterations in P-adrenoceptor density and/or function in various vascular beds can changc significantly during aging (17) (18) (19) (20) and possibly modulate cerebrovascular reactivity to NE (21) . The purpose of this investigation was to evaluate the potential role of P-adrenergic receptor activity and/or NO synthase in the age-dependent alteration of the cerebrovascular contractile response to NE in the fetal and newborn lamb. The middle cerebral artery (MCA) and basilar artery (BA) have been the most widely studied cerebral arteries, in vitro, in adults and fetuses. Therefore, the contractile response to NE of MCA and BA isolated from fetal (0.70 to 0.83 gestation) and newborn lambs were evaluated and compared using tissue bath technique. For each artery studied, parallel experiments were performed in the presence of the P,,P,-adrenoceptor antagonist, propranolol, or the NO synthase inhibitor, N~-nitro-L-arginine methyl csler (LNAME) in addition to propranolol.
METHODS
Newborn lambs were killed with pentobarbital sodium (115 mg/kg, i.v.). Pregnant ewes and fetuses were similarly killed, and the fetuses were removed. The skull was opened and the brain was rapidly removed and placed into a dissecting dish containing physiologic saline. Under a dissecting microscope ( l o x ) , MCAs and BAS were dissected free from the pial surface and immediately placed in Kreb's buffer with the following composition (mM): NaCl (128), KC1 (5), CaCl, (2.5), MgCl, (1.2), NaHCO, (22) , NaH,P04 (1.2), and glucose (11.5). The removed arteries were cut into 3-4-mm long ring segments, and each segment was gently mounted on stainless steel triangles (0.005-inch diameter) and suspended horizontally between a Grass force transducer (FT.03C) and a micrometer-controlled post. The glass tissue chamber (10 mL) was filled with the buffer, bubbled with 95% 0, + 5% CO,, and warmed to 37°C by a circulating water bath. The suspended vessels were stretched to a resting tension of 0.75 g/3-mm ring length (the optimal tension for maximum active contraction based on length-tension studies; data not shown) and maintained at a steady state resting tension in the bath for at least 60 min before beginning the experiments. Then the rings were induced to contract by replacing the Kreb's solution with potassium-Kreb's solution (10 mL) containing 120 mM KC1 and 13 rnM NaCl (KC1 stimulus). Once the peak contraction was obtained, the bath was washed with the normal Kreb's buffer, and the rings were allowed to return to their normal resting tension. This was repeated until the magnitude of successive KC1 contractions was closely matched. The peak response to the KC1 stimulus was used as a reference point for standardizing the subsequent experimental responses to contractile stimuli (9, 17) . In select arteries the functional integrity of endothelium was confirmed by the presence of a relaxation to the addition of calcium ionophore, A23187 (lop6 M), to rings precontracted with NE (22) (23) (24) .
Experiments were performed on a total of 52 MCA and 35 BA segments isolated from four preterm fetal lambs (105 d of gestation), seven near-term fetal lambs (125-130 d of gestation), and eight newborn lambs (2-7 d of age). Four to eight MCA ring segments and two to four BA ring segments were obtained from each animal and were placed in tissue bath as described. Cumulative dose response curves to NE ( 1 0~~-1 0 -~ M) were performed in the presence of propranolol M) or propranolol + LNAME M). Control (untreated) segments were run in parallel with the treated samples. Propranolo1 and LNAME were added to the bath at 20 and 10 min before beginning the NE dose-response determination, respectively. In some cases, the addition of LNAME caused a modest contraction (see Results). In those cases, the new steady state tension was taken as baseline for the purpose of the evaluating the subsequent NE response.
All compounds were prepared immediately before use in the tissue bath. Norepinephrine-HC1, propranolol-HC1, N~-nitro-L-arginine methyl ester-HC1, and A23187 were purchased from Research Biochemicals Inc., Natick, MA.
Statistical Analysis. Values are presented as means rt SEM. The contractile force generated by each ring segment obtained from preterm fetus, near-term fetus, and newborn lamb cerebral arteries was normalized to the maximal force generated by that same segment to 120 mM KCl. Each dose-response curve was fit to the Hill equation and the EC,, (effective NE concentration inducing 50% of maximal contraction) was determined. Differences in the EC,, were identified by analysis of variance with repeated measures when appropriate. The arterial responses to NE and the effect of inhibitors were analyzed with a two-way analysis of variance with repeated measures; factor A was developmental age, factor B was inhibitor treatment. Student-Newman-Kuels test was used when appropriate. Differences were considered significant when p 5 0.05.
RESULTS
The maximal contractile force generated in response to KC1 challenge increased significantly with gestational age from 1.07 -+ 0.08 g to 2.56 + 0.27 g and 3.29 + 0.23 g for preterm fetus MCA, near-term fetus MCA, and newborn lamb MCA, respectively ( y < 0.05), which is consistent with the increase in vessel wall thickness that occurs during development (9) . The maximal contractile forces generated in response to KC1 challenge by near-term fetus BA and newborn lamb BA were not different, 2.45 + 0.25 and 2.42 -C 0.19 g, respectively.
Preterm fetus BA was not studied.
The maximal force (F,,,) generated in response to NE, when expressed in absolute grams of force per ring, did not change with development (1.10 + 0.17, 1.02 + 0.12, and 1.05 + 0.38 g for preterm fetus, near-term fetus, and newborn lamb MCA, respectively). However, when normalized to the respective KC1 response, the F,,, in response to NE was significantly decreased as a function of gestational age (Fig. 1, Table 1 ); to one-half for near-term fetus and to one-third for newborn lamb MCA, compared with that of preterm fetus MCA. There was also a significant decrease in sensitivity to NE during fetal development as manifested by an increase in the EC,, from 0.14 + 0.03, 1.09 +. 0.36, and 1.07 + 0.22 p M for preterm fetus, near-term fetus, and newborn lamb MCA, respectively (Table 1) . BA from newborn lamb and near-term fetuses did not respond to NE.
The effects of propranolol and propranolol + LNAME on the contractile response to NE for the three developmental age groups are presented in Table 1 and in Figures 2 and 3 for MCA and BA, respectively. Propranolol significantly augmented the NE-induced contraction in newborn lamb MCA, manifested by an increase in F, , , .
Propranolol did not significantly affect the NE response in either near-term or preterm fetus MCA. Propranolol + LNAME significantly augmented the NE-induced contraction in near-term fetus MCA as manifested by a 2-fold increase in the F,,, and a 7-fold decrease in the EC,,. Propranolol + LNAME also significantly augmented the NE response in newborn lamb MCA, however, it was not different from that of propranolol alone. Propranolol + LNAME did not affect the NE-induced contraction in the preterm fetus MCA. After propranolol + LNAME treatment, the response to NE for near-term fetal lamb MCA was no longer significantly different from that of preterm fetal lamb and Table 1 ). Subsequent LNAME treatment, however, did Norepinephrine (M) Figure 1 . Dose-response curve for norepinephrine-induced contraction of middle cerebral artery rings isolated from newborn lambs (O), near-term fetal lambs (W) and preterm fetal lambs (A). Force of contraction is expressed as percent of the maximal force attained for the same preparations in response to 120 mM KC1 challenge. F,,,, EC,,, and number of arteries are given in Table  1 . There was a statistically significant interaction between gestational age and norepinephrine concentration ( p < 0.05) by two-way analysis of variance.
Values are mean t SEM.
Administration of propranolol (10F5 M) to the tissue bath had no effect on the baseline tension of MCAs or BAS for any of the age groups. The subsequent addition of LNAME M) to the tissue bath, however, caused contraction in all three age groups (14 +-5, 14 t 5, and 2 i-1% of KC1 response for preterm fetus, near-term fetus, and newborn lamb, respectively). The magnitude of the contraction induced by LNAME was significantly diminished in the newborn lamb MCA when compared with both preterm and near-term fetus MCA (p < 0.001).
expose a small contractile response to NE in three of five newborn lamb BA. LNAME treatment also significantly augmented the previously absent response to NE for near-term fetal lamb BA. Preterm fetal BA was not studied.
DISCUSSION
The findings of the present study offer evidence for at least two vascular regulatory elements, i.e. N'O synthase activity and P-adrenoceptor activity, which may play a role in the functional attenuation of NE reactivity of the cerebral circulation during perinatal development in sheep. Both regulatory elements appear to be activated by NE and both act to modify the NE-induced contraction of cerebral arteries. The NE-induced NO synthase activity appears to be the dominant endogenous inhibitor pathway operating late in fetal life and perhaps is more efficacious because of its influence even at low concentrations of NE. P-Adrenoceptor activation may also play a significant role in attenuating the NE-induced contraction during postnatal life but may be limited to the high concentration range of NE. The data suggest that NO formation by vascular Propranolol concentration was 10 pM. LNAME, 100 pM. NR signifies no response to norepinephrine. Number of arteries are in Parentheses. Preterm fetus basilar arteries were not studied.
" Significantly different from preterm fetus.
i Significantly different from control; p 5 0.05. Figure 3 . EKCCL of P-adrenergic antagonist, propranolol (10 p M ) and LNAME (100 p M ) on the norepinephrine-induced contraction of basilar artcry rings ( 0 , control; 0, propranolol; A, propranolol + LNAME) isolated from near-term fetal lambs (left pa~zel) and newborn lambs (riglzt purzel). F,,,,,, EC,,,, and number of artcries are given in Table 1 . Values are mean -t SEM.
endothelial cells plays an important role in the modulation of cerebrovascular a-adrenergic contraction during fetal development.
These conclusions are based on the finding that the respective pattern and efficacy of NO synthase inhibition and 0-adrenoceptor blockade on the characteristic NE-induced contraction of MCA was distinctive for each developmental age group studied. Neither NO synthase inhibition nor 0-adrenergic blockade further enhanced the already substantial response of preterm fetus MCA to NE. In contrast, the response of the near-term fetus MCA to NE was significantly diminished from that of preterm fetus and NO synthase inhibition markedly increased both the relative force of contraction and sensitivity to the neurotransmitter. Indeed, the response of near-term fetus MCA to NE in the presence of LNAME was not significantly different from that of the untreated preterm fetus MCA. Finally, the NE response of newborn lamb MCA was augmented significantly by propranolol whereas the addition of LNAME had little further effect.
In both fetal and newborn lambs, the characteristic response of the BA to NE differed from that of the MCA as was previously reportcd (9) . In the present study, the BA was unresponsive to NE; however, a significant contractile rcsponse could be elicitcd for the BA, predominately in the near-term fetus, in the prcsence of LNAME. Thus, in near-term fetus BA as well, vascular production of NO, presumably via endothelium, dramatically attenuates a-adrenergic contraction.
The LNAME-sensitive component of the NE responsiveness observed for the near-term fetus MCA is most probably that of constitutive NO synthase activity expressed in vascular endothelium (25) , although NO generated by vascular smooth muscle cells may also occur (26, 27) . For that matter, administration of LNAME, in and of itself, contracted MCAs of both preterm and near-term fetuses suggesting that therc was constitutive NO synthase activity even in the absence of NE in the MCAs of both fetal ages. However, LNAME augmented the NE response only in the MCAs from the near-term fetuses. Thus, the presencc or absence of spontaneously released NO was probably not singularly responsible for the diminished NE-induced contraction observcd with maturation. It is likely, therefore, that for the near-term fetus MCA, NE stimulated an increase in NO formation via vascular a-adrenoceptors presumably located on the endothelium (10).
Endothelium removal has been shown to enhance the maximum force of contraction and sensitivity of aorta and mesenteric arteries of adult rats to both a,-and a,-adrenergic agonists (12, 13) . In other cases, endothelium-dependent modulation of NE-induced contraction appears to involve primarily a,-adrenoceptors located on endothelial cells. In fact, a,-adrenergic agonists havc bcen shown to cause cndotheliumdependent relaxation in select vascular preparations (10, 11, 14) . Thus, in the near-term fetus and newborn lamb MCA as well, NE probably stimulated endothelium formation of NO via either a , -and/or a,-adrenoceptors. Furthermore, the implication of this study that endothelium-dependent modulation of cerebrovascular adrenergic reactivity is dependent on developmental age may be consistent with reports of differential expression of vascular a , -and a,-adrenoceptors during development (1, 28, 29) .
Pearce et al. (9) , have reported dcvelopmental changes in both morphology and reactivity of cerebral arteries from term fetal lambs (139-141 d of gestation) and newborn lambs (3-7 d old). Specifically, the transition from fetal life was associated with a decrease in vessel water content, an increase in vessel wall stiffness and thickness, an increase in the maximum active stress development, and a decrease in the maximum contractile responsc to amines (serotonin and NE). Our findings support the latter observation and extend it to earlier stages of fetal development. The relative force of contraction induced by NE in preterm fctus MCAs was significantly enhanced compared with that of near-term fetus MCAs and newborn lamb MCAs and there was a significant decrease in sensitivity (i.e. increase in EC,,) as a function of developmental age, exposing the relative incrcased efficiency for NE-induced force generation in the immature cerebral circulation.
From a functional standpoint, the more efficient contractility of premature cerebral arteries to the neurotransmitter would likely precipitate a more potent sympathetic vasoconstriction, in vivo. Thus, reflex activation of sympathetic nerves andlor humoral activation of vascular adrenoceptors may significantly decrease cerebral perfusion. Using the closed cranial window preparation, we have previously shown that NE-induced vasoconstriction of cerebral arteries, in vivo, was enhanced in preterm fetuses of <I20 d of gestation compared with newborn lambs (8) . Furthermore, fetal lambs as early as 111 d of gestation, approximately the same age as the preterm fetuses of the present study, exhibited a functional sympathetic innervation of cerebral arterioles, which, when stimulated, induced vasoconstriction (8) . In newborn pigs, sympathetic nerves significantly reduce cerebral blood flow during pathophysiologic events known to be associated with sympatho-adrenal activation, i.e. bicuculline-induced seizures (30) and acute asphyxia (31, 32) . Whether sympathetic vasoconstriction significantly attenuates cerebral blood flow in the fetus has yet to be determined; however, it was postulated that immature neuroeffector mechanism(s) may be a factor in the diminished cerebral blood flow response to hypoxemia reported in premature fetal sheep (33) .
With regard to the possible effects of blood-borne NE on fetal cerebral arteries, elevation of plasma NE was reported to have no effect on cerebral blood flow in fetal sheep of 125-135 d of gestation, suggesting that the blood-brain barrier to catecholamines has developed (34) . On the other hand, a functional endothelium so exposed to circulating NE may produce NO and thus mask any vasoconstriction in that model. In less mature fetuses, however, the enhanced reactivity to NE may become important, especially in the presence of even minor damage to the blood-brain barrier. It seems readily apparent that a well developed endothelium may be critical to the prevention of unmitigated vasoconstriction in response to sympatho-adrenal activation in the fetal cerebral circulation.
In adult animal models, the neuroeffector system in cerebral arteries generally exhibits unique features, distinct from those commonly observed for peripheral arteries (1) . These features include a reduced capacity to elicit maximal contraction, limited receptor reserve, reduced NE sensitivity, possible expression of unique a-adrenoceptor subtypes, relatively small vasoconstrictor responses to sympathetic stimulation, and when sympathetic vasoconstriction is present, it is limited to large arteries. The present study along with previous reports (4, 6, 30, 31) , however, demonstrate a remarkable capacity for sympathetic regulation of cerebral blood flow during the perinatal period that is specifically diminished as the animals mature (7) (8) (9) 28) . Indeed, preterm fetal lamb MCA exhibited a NE sensitivity (EC,, = 1.4 X 10F7 M) and a capacity to elicit a maximal contraction (100% of KC1 contraction) that were virtually identical to that normally attributed to noncerebral arteries (1) . It would appear that the development of a functional neuroeffector system in the cerebral circulation precedes that of certain important endogenous inhibitory systems, such as a NE sensitive NO-generating system and/or functional vascular P-adrenoceptors. Therefore, we may surmise that the atypical behavior of the neuroeffector system of adult cerebral arteries reflects the ontogeny of functional suppression of sympathetic reactivity.
In adult sheep MCA, endothelium removal had no effect on the contractile response either to NE or 1. 0 serotonin (35) . In the present study, neither propranolol nor LNAME completely restored the reactivity of newborn lamb MCA to NE to that observed for preterm fetuses. These findings suggest that additional, as yet, unidentified factors may come into play to modulate NE reactivity as the cerebral circulation matures. Certainly, other endogenously produced factors, i.e. eicosanoids, could similarly modulate sympathetic vasoconstriction in neonates (36) . Also, postnatal changes in vascular and/or endothelial cell adrenoceptor expression and density occur with development (17, 28) . This may explain, in part, reports that cerebral arteries of adult pigs exhibited only P-adrenergic vasodilation in response to NE whereas neonatal pigs exhibited vasoconstriction via vascular a,-and a,-adrenoceptors (3, 21, 37) . Finally, an alternative process perhaps modulating NE reactivity could entail changes in postreceptor signaling mechanisms during development (38) .
In conclusion, these findings implicate a NO synthasedependent pathway in fetal lamb cerebral arteries that exerts functional inhibition of the contraction induced by sympathetic activation and is expressed during the last third of gestation. Subsequent maturation of vascular P-adrenergic receptors may supplant this role in the newborn cerebral circulation. The data suggest that, in the more mature fetus, NO behaves as a functional antagonist to sympathetic vasoconstriction of the cerebrovasculature, and its apparent absence permits unrepressed sympathetic vasoconstriction in the premature brain.
